Standard Chartered PLC
LSE:STAN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Standard Chartered PLC
LSE:STAN
|
UK |
|
Fortress Biotech Inc
NASDAQ:FBIO
|
US |
|
Central Pattana PCL
SET:CPN
|
TH |
|
E
|
Elica SpA
F:7L4
|
IT |
|
P
|
Premier Foods PLC
F:FOJ1
|
UK |
|
Margaret Lake Diamonds Inc
OTC:KNXFF
|
CA |
|
Flame Acquisition Corp
NYSE:SOC
|
US |
|
Boston Beer Company Inc
NYSE:SAM
|
US |
|
I
|
Icade SA
OTC:CDMGF
|
FR |
|
A
|
Active Biotech AB publ
F:BTPC
|
SE |
|
M
|
Mersana Therapeutics Inc
SWB:0M4
|
US |
Wall St Price Targets
STAN Price Targets Summary
Standard Chartered PLC
According to Wall Street analysts, the average 1-year price target for STAN is 2 123.3 GBX with a low forecast of 1 515 GBX and a high forecast of 2 520 GBX.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is STAN's stock price target?
Price Target
2 123.3
GBX
According to Wall Street analysts, the average 1-year price target for STAN is 2 123.3 GBX with a low forecast of 1 515 GBX and a high forecast of 2 520 GBX.
What is the Revenue forecast for Standard Chartered PLC?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 5 years is 5%.
What is the Net Income forecast for Standard Chartered PLC?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 5 years is 12%.
